BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16424557)

  • 1. Voriconazole.
    Naithani R; Kumar R
    Indian Pediatr; 2005 Dec; 42(12):1207-12. PubMed ID: 16424557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voriconazole: a new triazole antifungal agent.
    Johnson LB; Kauffman CA
    Clin Infect Dis; 2003 Mar; 36(5):630-7. PubMed ID: 12594645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voriconazole in newborns.
    Kohli V; Taneja V; Sachdev P; Joshi R
    Indian Pediatr; 2008 Mar; 45(3):236-8. PubMed ID: 18367773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experience with voriconazole in invasive aspergillosis].
    Thiel E; Schwartz S
    Mycoses; 2003; 46 Suppl 2():3-7. PubMed ID: 15055137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voriconazole: a broad-spectrum triazole for the treatment of invasive fungal infections.
    Cecil JA; Wenzel RP
    Expert Rev Hematol; 2009 Jun; 2(3):237-54. PubMed ID: 21082966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Voriconazole - applications and perspectives].
    Ruhnke M
    Mycoses; 2002; 45 Suppl 3():42-7. PubMed ID: 12690971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.
    Berge M; Guillemain R; Boussaud V; Pham MH; Chevalier P; Batisse A; Amrein C; Dannaoui E; Loriot MA; Lillo-Le Louet A; Billaud EM
    Transpl Infect Dis; 2009 Jun; 11(3):211-9. PubMed ID: 19302272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology and clinical use of voriconazole.
    Thompson GR; Lewis JS
    Expert Opin Drug Metab Toxicol; 2010 Jan; 6(1):83-94. PubMed ID: 19947892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voriconazole: a new triazole antifungal.
    Sabo JA; Abdel-Rahman SM
    Ann Pharmacother; 2000 Sep; 34(9):1032-43. PubMed ID: 10981251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New antifungal agents: voriconazole and caspofungin].
    Dupont B
    Arch Pediatr; 2003 Dec; 10 Suppl 5():592s-598s. PubMed ID: 15022787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole.
    Ullmann AJ
    Curr Med Res Opin; 2003; 19(4):263-71. PubMed ID: 12841918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of Candida albicans fungemia during voriconazole therapy.
    Mohammedi I; Thiebaut A; Piens MA; Argaud L; Martin O; Robert D
    J Infect; 2005 Oct; 51(3):e83-4. PubMed ID: 16230209
    [No Abstract]   [Full Text] [Related]  

  • 13. Voriconazole treatment for less-common, emerging, or refractory fungal infections.
    Perfect JR; Marr KA; Walsh TJ; Greenberg RN; DuPont B; de la Torre-Cisneros J; Just-NĂ¼bling G; Schlamm HT; Lutsar I; Espinel-Ingroff A; Johnson E
    Clin Infect Dis; 2003 May; 36(9):1122-31. PubMed ID: 12715306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Voriconazole-medicalneeds, evidence, potential for the future].
    Shirasawa H; Nagino K
    Nihon Ishinkin Gakkai Zasshi; 2005; 46(4):223-8. PubMed ID: 16282963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voriconazole.
    Med Lett Drugs Ther; 2002 Jul; 44(1135):63-5. PubMed ID: 12138377
    [No Abstract]   [Full Text] [Related]  

  • 16. [The role of voriconazole in the treatment of emerging mycoses].
    Pastor FJ; Guarro J
    Rev Iberoam Micol; 2007 Sep; 24(3):228-32. PubMed ID: 17874861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voriconazole versus amphotericin B for invasive aspergillosis.
    Karthaus M
    N Engl J Med; 2002 Dec; 347(25):2080-1; author reply 2080-1. PubMed ID: 12494937
    [No Abstract]   [Full Text] [Related]  

  • 18. Voriconazole: in the treatment of invasive aspergillosis.
    Muijsers RB; Goa KL; Scott LJ
    Drugs; 2002; 62(18):2655-64; discussion 2665-6. PubMed ID: 12466006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voriconazole for serious fungal infections.
    Gothard P; Rogers TR
    Int J Clin Pract; 2004 Jan; 58(1):74-80. PubMed ID: 14994974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
    Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.